People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nexgel, Inc. | — | Biotechnology | Seed | $4.6M | $37.6M | 2019 |
Adam R. Levy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam R. Levy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jerome Zeldis | 1 | 6 |
| Richard Rosenblum | 1 | 6 |
| Adam Levy | 1 | 3 |
| David Stefansky | 1 | 3 |
| Benjamin Mayer | 1 | 2 |
| Miranda J Toledano | 1 | 1 |
| Steven Mark Glassman | 1 | 1 |
| David R. Stefansky | 1 | 1 |
| Nachum R. Stein | 1 | 1 |
| Joe R. Williams | 1 | 1 |
| Michael W Chorske | 1 | 1 |
| Nachum Stein | 1 | 1 |
| Adam J Drapczuk | 1 | 1 |
| Yaakov J Spinrad | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.